home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A 'Retro' Alternative For Immunology Researchers

  March, 1 2006 8:49
your information resource in human molecular genetics
A simple strategy for creating mice that express multiple foreign proteins could help some scientists to study essential processes of immune development without the trouble of transgenics, as described in the March 2006 issue of Nature Methods.

Immature T cells produce a variety of multi-subunit T cell receptors (TCRs), which exhibit enormous sequence variability. Proper maturation depends on the extent to which a T cell's TCRs can interact with host-specific major histocompatibility complex (MHC) proteins. If this interaction is too strong or too weak, maturation will not take place. Immunologists have typically studied this important process in vivo via TCR engineering, generating transgenic animals that exclusively produce T cells expressing TCRs with specific subunit combinations.

Dario Vignali's laboratory previously described a system that enables single DNA molecules to act as 'assembly lines' for the simultaneous production of multiple, independent proteins. Here the team adapt this method to generate retroviral constructs expressing multiple TCR subunits, which were used to infect mouse marrow stem cells. These cells are transplanted into marrow-depleted recipients to make 'retrogenic' mice that produce only one type of TCR. This approach bypasses the time and trouble of generating and crossing multiple transgenic strains, and ensures equal production of all protein products-an essential consideration for TCR assembly.

In an associated 'News and Views' piece, Rémy Bosselut comments that although these retrogenics may not fully supplant transgenics for studying TCR-MHC interactions in vivo, they offer a rapid and elegant alternative for TCR mutant analysis or experimental scenarios where standard transgenics aren't an option.

Author contact:

Dario A. A. Vignali (St. Jude Children's Research Hospital, Memphis, TN, USA)
Email: dario.vignali@stjude.org

Rémy Bosselut (National Cancer Insitute, Bethesda, MD, USA)
Email: remy@helix.nih.gov

Abstract available online.

(C) Nature Methods press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.